Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN
Stegelmann F, Wille K, Busen H, Fuchs C, Schauer S, Sadjadian P, Becker T, Kolatzki V, Döhner H, Stadler R, Döhner K, et al. (2021)
Leukemia 35: 628-631.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Stegelmann, Frank;
Wille, Kai;
Busen, HannahUniBi 
;
Fuchs, ChristianeUniBi ;
Schauer, Stefanie;
Sadjadian, Parvis;
Becker, Tatjana;
Kolatzki, Vera;
Döhner, Hartmut;
Stadler, Rudolf;
Döhner, Konstanze;
Griesshammer, Martin
Alle
;
Fuchs, ChristianeUniBi ;
Schauer, Stefanie;
Sadjadian, Parvis;
Becker, Tatjana;
Kolatzki, Vera;
Döhner, Hartmut;
Stadler, Rudolf;
Döhner, Konstanze;
Griesshammer, Martin
Alle
Stichworte
Anesthesiology and Pain Medicine;
Cancer Research;
Hematology
Erscheinungsjahr
2021
Zeitschriftentitel
Leukemia
Band
35
Seite(n)
628-631
ISSN
0887-6924
eISSN
1476-5551
Page URI
https://pub.uni-bielefeld.de/record/2944734
Zitieren
Stegelmann F, Wille K, Busen H, et al. Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia. 2021;35:628-631.
Stegelmann, F., Wille, K., Busen, H., Fuchs, C., Schauer, S., Sadjadian, P., Becker, T., et al. (2021). Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia, 35, 628-631. https://doi.org/10.1038/s41375-020-0945-3
Stegelmann, Frank, Wille, Kai, Busen, Hannah, Fuchs, Christiane, Schauer, Stefanie, Sadjadian, Parvis, Becker, Tatjana, et al. 2021. “Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN”. Leukemia 35: 628-631.
Stegelmann, F., Wille, K., Busen, H., Fuchs, C., Schauer, S., Sadjadian, P., Becker, T., Kolatzki, V., Döhner, H., Stadler, R., et al. (2021). Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia 35, 628-631.
Stegelmann, F., et al., 2021. Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia, 35, p 628-631.
F. Stegelmann, et al., “Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN”, Leukemia, vol. 35, 2021, pp. 628-631.
Stegelmann, F., Wille, K., Busen, H., Fuchs, C., Schauer, S., Sadjadian, P., Becker, T., Kolatzki, V., Döhner, H., Stadler, R., Döhner, K., Griesshammer, M.: Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN. Leukemia. 35, 628-631 (2021).
Stegelmann, Frank, Wille, Kai, Busen, Hannah, Fuchs, Christiane, Schauer, Stefanie, Sadjadian, Parvis, Becker, Tatjana, Kolatzki, Vera, Döhner, Hartmut, Stadler, Rudolf, Döhner, Konstanze, and Griesshammer, Martin. “Significant association of cutaneous adverse events with hydroxyurea: results from a prospective non-interventional study in BCR-ABL1-negative myeloproliferative neoplasms (MPN) - on behalf of the German Study Group-MPN”. Leukemia 35 (2021): 628-631.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Quellen
PMID: 32616864
PubMed | Europe PMC
Suchen in
Google Scholar